Wells Fargo Sees Upside to Boston Scientific (BSX) After Hosting NDR

August 2, 2021 7:44 AM EDT Send to a Friend
Wells Fargo analyst Lawrence Biegelsen reiterated an Overweight rating and $52.50 price target on Boston Scientific (NYSE: BSX) after hosting ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login